Angela Hwang, Group President of the Pfizer Biopharmaceuticals Group

Dig­i­tal tech boost­ed Pfiz­er com­mer­cial, R&D gains dur­ing Covid — and there’s no go­ing back, ex­ecs say

Pfiz­er went dig­i­tal in a big way dur­ing the Covid pan­dem­ic — and it’s not go­ing back, ex­ec­u­tives said at Cowen’s an­nu­al health­care con­fer­ence on Mon­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.